Favorable clinical course after early-intensive immunotherapy for new-onset refractory status epilepticus
Background New-onset refractory status epilepticus (NORSE) refers to the newly established concept of a disease characterized by refractory status epilepticus without an identifiable etiology. Recent reports have indicated the importance of immunotherapy for NORSE. Case Report A 37-year-old man with...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Korean Neurocritical Care Society
2020-06-01
|
| Series: | Journal of Neurocritical Care |
| Subjects: | |
| Online Access: | http://www.e-jnc.org/upload/pdf/jnc-190115.pdf |